Literature DB >> 20944061

Nonenzymatic free radical-catalyzed generation of 15-deoxy-Δ(12,14)-prostaglandin J₂-like compounds (deoxy-J₂-isoprostanes) in vivo.

Klarissa D Hardy1, Brian E Cox, Ginger L Milne, Huiyong Yin, L Jackson Roberts.   

Abstract

15-Deoxy-Δ(12,14)-prostaglandin J₂ (15-d-PGJ₂) is a reactive cyclopentenone eicosanoid generated from the dehydration of cyclooxygenase-derived prostaglandin D₂ (PGD₂). This compound possesses an α,β-unsaturated carbonyl moiety that can readily adduct thiol-containing biomolecules such as glutathione and cysteine residues of proteins via the Michael addition. Due to its reactivity, 15-d-PGJ₂ is thought to modulate inflammatory and apoptotic processes and is believed to be an endogenous ligand for peroxisome proliferator-activated receptor-γ. However, the extent to which 15-d-PGJ₂ is formed in vivo and the mechanisms that regulate its formation are unknown. Previously, we have reported the formation of PGD₂ and PGJ₂-like compounds, termed D₂/J₂-isoprostanes (D₂/J₂-IsoPs), produced in vivo by the free radical-catalyzed peroxidation of arachidonic acid (AA). Based on these findings, we investigated whether 15-d-PGJ₂-like compounds are also formed via this nonenzymatic pathway. Here we report the generation of novel 15-d-PGJ₂-like compounds, termed deoxy-J₂-isoprostanes (deoxy-J₂-IsoPs), in vivo, via the nonenzymatic peroxidation of AA. Levels of deoxy-J₂-IsoPs increased 12-fold (6.4 ± 1.1 ng/g liver) in rats after oxidant insult by CCl₄ treatment, compared with basal levels (0.55 ± 0.21 ng/g liver). These compounds may have important bioactivities in vivo under conditions associated with oxidant stress.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20944061      PMCID: PMC2999919          DOI: 10.1194/jlr.M010264

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  57 in total

Review 1.  Cyclooxygenase mechanisms.

Authors:  L J Marnett
Journal:  Curr Opin Chem Biol       Date:  2000-10       Impact factor: 8.822

Review 2.  Cyclopentenone prostaglandins: new insights on biological activities and cellular targets.

Authors:  D S Straus; C K Glass
Journal:  Med Res Rev       Date:  2001-05       Impact factor: 12.944

Review 3.  Letter: PGA: fact, not artifact.

Authors:  A Attallah; W Payakkapan; J Lee; A Carr; E Brazelton
Journal:  Prostaglandins       Date:  1974-01-10

4.  15-deoxy-delta 12,14-prostaglandin J2. A prostaglandin D2 metabolite generated during inflammatory processes.

Authors:  Takahiro Shibata; Mitsuhiro Kondo; Toshihiko Osawa; Noriyuki Shibata; Makio Kobayashi; Koji Uchida
Journal:  J Biol Chem       Date:  2002-01-10       Impact factor: 5.157

5.  Contribution of cyclopentenone prostaglandins to the resolution of inflammation through the potentiation of apoptosis in activated macrophages.

Authors:  S Hortelano; A Castrillo; A M Alvarez; L Boscá
Journal:  J Immunol       Date:  2000-12-01       Impact factor: 5.422

Review 6.  The oxidative modification hypothesis of atherogenesis: an overview.

Authors:  G M Chisolm; D Steinberg
Journal:  Free Radic Biol Med       Date:  2000-06-15       Impact factor: 7.376

7.  Biphasic effects of 15-deoxy-delta(12,14)-prostaglandin J(2) on glutathione induction and apoptosis in human endothelial cells.

Authors:  A L Levonen; D A Dickinson; D R Moellering; R T Mulcahy; H J Forman; V M Darley-Usmar
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-11       Impact factor: 8.311

8.  The cyclopentenone product of lipid peroxidation, 15-A(2t)-isoprostane (8-isoprostaglandin A(2)), is efficiently conjugated with glutathione by human and rat glutathione transferase A4-4.

Authors:  Ina Hubatsch; Bengt Mannervik; Ling Gao; L Jackson Roberts; Yan Chen; Jason D Morrow
Journal:  Chem Res Toxicol       Date:  2002-09       Impact factor: 3.739

9.  Human colorectal cancer cells efficiently conjugate the cyclopentenone prostaglandin, prostaglandin J(2), to glutathione.

Authors:  Brian Cox; Laine J Murphey; William E Zackert; Rebecca Chinery; Ramona Graves-Deal; Olivier Boutaud; John A Oates; Robert J Coffey; Jason D Morrow
Journal:  Biochim Biophys Acta       Date:  2002-09-05

10.  Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants.

Authors:  Albena T Dinkova-Kostova; W David Holtzclaw; Robert N Cole; Ken Itoh; Nobunao Wakabayashi; Yasutake Katoh; Masayuki Yamamoto; Paul Talalay
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-22       Impact factor: 11.205

View more
  13 in total

Review 1.  Protein modifications by electrophilic lipoxidation products: adduct formation, chemical strategies and tandem mass spectrometry for their detection and identification.

Authors:  Yury V Vasil'ev; Shin-Chen Tzeng; Lin Huang; Claudia S Maier
Journal:  Mass Spectrom Rev       Date:  2014 May-Jun       Impact factor: 10.946

Review 2.  The isoprostanes--25 years later.

Authors:  Ginger L Milne; Qi Dai; L Jackson Roberts
Journal:  Biochim Biophys Acta       Date:  2014-10-30

Review 3.  Isoprostane generation and function.

Authors:  Ginger L Milne; Huiyong Yin; Klarissa D Hardy; Sean S Davies; L Jackson Roberts
Journal:  Chem Rev       Date:  2011-08-18       Impact factor: 60.622

4.  Identification of a novel series of anti-inflammatory and anti-oxidative phospholipid oxidation products containing the cyclopentenone moiety in vitro and in vivo: Implication in atherosclerosis.

Authors:  Jianhong Lu; Shuyuan Guo; Xinli Xue; Qun Chen; Jing Ge; Yujuan Zhuo; Huiqin Zhong; Buxing Chen; Mingming Zhao; Wei Han; Takashi Suzuki; Mingjiang Zhu; Lin Xia; Claus Schneider; Timothy S Blackwell; Ned A Porter; Lemin Zheng; Sotirios Tsimikas; Huiyong Yin
Journal:  J Biol Chem       Date:  2017-02-15       Impact factor: 5.157

Review 5.  Redox-dependent anti-inflammatory signaling actions of unsaturated fatty acids.

Authors:  Meghan Delmastro-Greenwood; Bruce A Freeman; Stacy Gelhaus Wendell
Journal:  Annu Rev Physiol       Date:  2013-10-16       Impact factor: 19.318

6.  Analysis of eicosanoid oxidation products in Alzheimer brain by LC-MS with uniformly 13C-labeled internal standards.

Authors:  Ran Furman; Jin V Lee; Paul H Axelsen
Journal:  Free Radic Biol Med       Date:  2018-02-21       Impact factor: 7.376

Review 7.  Pathophysiology of isoprostanes in the cardiovascular system: implications of isoprostane-mediated thromboxane A2 receptor activation.

Authors:  Jochen Bauer; Anne Ripperger; Stefan Frantz; Süleyman Ergün; Edzard Schwedhelm; Ralf A Benndorf
Journal:  Br J Pharmacol       Date:  2014-07       Impact factor: 8.739

8.  Prostaglandin 15d-PGJ(2) inhibits androgen receptor signaling in prostate cancer cells.

Authors:  Sanna Kaikkonen; Ville Paakinaho; Päivi Sutinen; Anna-Liisa Levonen; Jorma J Palvimo
Journal:  Mol Endocrinol       Date:  2012-11-28

Review 9.  Isoprostanes and neuroprostanes as biomarkers of oxidative stress in neurodegenerative diseases.

Authors:  Elżbieta Miller; Agnieszka Morel; Luciano Saso; Joanna Saluk
Journal:  Oxid Med Cell Longev       Date:  2014-04-29       Impact factor: 6.543

10.  Sustained Isoprostane E2 Elevation, Inflammation and Fibrosis after Acute Ischaemia-Reperfusion Injury Are Reduced by Pregnane X Receptor Activation.

Authors:  Aimen O Amer; Philip M Probert; Michael Dunn; Margaret Knight; Abigail E Vallance; Paul A Flecknell; Fiona Oakley; Iain Cameron; Steven A White; Peter G Blain; Matthew C Wright
Journal:  PLoS One       Date:  2015-08-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.